A For Ayurveda Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 20-06-2024
- Paid Up Capital ₹ 0.10 M
as on 20-06-2024
- Company Age 10 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 12.30%
(FY 2022)
- Profit -87.95%
(FY 2022)
- Ebitda -66.45%
(FY 2022)
- Net Worth 2.01%
(FY 2022)
- Total Assets 10.61%
(FY 2022)
About A For Ayurveda
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bhavesh Joshi, Pravinbhai Hirpara, Bhavdeep Ganatra, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24233GJ2014PTC079789
- Company No.
079789
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jun 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does A For Ayurveda Private Limited offer?
A For Ayurveda Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine.
Who are the key members and board of directors at A For Ayurveda?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhavesh Joshi  | Director | 13-Jun-2014 | Current |
| Bhavdeep Ganatra | Director | 01-Nov-2014 | Current |
| Pravinbhai Hirpara | Director | 01-Nov-2014 | Current |
| Vinay Vora | Director | 01-Nov-2014 | Current |
| Mukul Patel | Director | 01-Nov-2014 | Current |
| Tapanbhai Vaidya | Director | 13-Jun-2014 | Current |
Financial Performance of A For Ayurveda.
A For Ayurveda Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 12.3% increase. The company also saw a substantial fall in profitability, with a 87.95% decrease in profit. The company's net worth moved up by a moderate rise of 2.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of A For Ayurveda?
In 2020, A For Ayurveda had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Naroda Institute Of Medical Sciences Private LimitedActive 11 years 1 monthBhavesh Joshi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at A For Ayurveda?
Unlock and access historical data on people associated with A For Ayurveda, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of A For Ayurveda, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped A For Ayurveda's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
